Correlation Between Algorhythm Holdings, and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algorhythm Holdings, and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algorhythm Holdings, and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algorhythm Holdings, and Esperion Therapeutics, you can compare the effects of market volatilities on Algorhythm Holdings, and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algorhythm Holdings, with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algorhythm Holdings, and Esperion Therapeutics.

Diversification Opportunities for Algorhythm Holdings, and Esperion Therapeutics

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Algorhythm and Esperion is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Algorhythm Holdings, and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Algorhythm Holdings, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algorhythm Holdings, are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Algorhythm Holdings, i.e., Algorhythm Holdings, and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Algorhythm Holdings, and Esperion Therapeutics

Given the investment horizon of 90 days Algorhythm Holdings, is expected to under-perform the Esperion Therapeutics. In addition to that, Algorhythm Holdings, is 1.5 times more volatile than Esperion Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  153.00  in Esperion Therapeutics on September 12, 2024 and sell it today you would earn a total of  151.00  from holding Esperion Therapeutics or generate 98.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Algorhythm Holdings,  vs.  Esperion Therapeutics

 Performance 
       Timeline  
Algorhythm Holdings, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Algorhythm Holdings, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Esperion Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Algorhythm Holdings, and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algorhythm Holdings, and Esperion Therapeutics

The main advantage of trading using opposite Algorhythm Holdings, and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algorhythm Holdings, position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind Algorhythm Holdings, and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.